{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:58:29Z","timestamp":1776772709208,"version":"3.51.2"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.annepidem.2018.03.006","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T14:01:26Z","timestamp":1521468086000},"page":"440-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Long-term trends in antithrombotic drug prescriptions among adults aged 80\u00a0years and over from primary care: a temporal trends analysis using electronic health records"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7620-4902","authenticated-orcid":false,"given":"A.","family":"Dregan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ravindrarajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ashworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Molokhia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.annepidem.2018.03.006_bib1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"10042","key":"10.1016\/j.annepidem.2018.03.006_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(16)30468-8","article-title":"Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials","volume":"388","author":"Rothwell","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.annepidem.2018.03.006_bib3","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.annepidem.2018.03.006_bib4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.annepidem.2018.03.006_bib5","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIR.0b013e3181e3b133","volume":"121","author":"Pignone","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.annepidem.2018.03.006_bib6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0140-6736(17)30770-5","article-title":"Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study","volume":"390","author":"Li","year":"2017","journal-title":"Lancet"},{"issue":"9706","key":"10.1016\/j.annepidem.2018.03.006_bib7","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(09)61751-7","article-title":"Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data","volume":"374","author":"Sorensen","year":"2009","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.annepidem.2018.03.006_bib8","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.amjcard.2013.05.051","article-title":"Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United kingdom primary care","volume":"112","author":"Martin Merino","year":"2013","journal-title":"Am J Cardiol"},{"issue":"21","key":"10.1016\/j.annepidem.2018.03.006_bib9","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hylek","year":"2007","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.annepidem.2018.03.006_bib10","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States From 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.annepidem.2018.03.006_bib11","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jacc.2012.01.042","article-title":"Is patient frailty the unmeasured confounder that connects subacute stent thrombosis with increased periprocedural bleeding and increased mortality?","volume":"59","author":"Klein","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.annepidem.2018.03.006_bib12","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1056\/NEJMc1112874","article-title":"Bleeding risk with dabigatran in the frail elderly","volume":"366","author":"Harper","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.annepidem.2018.03.006_bib13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.amepre.2014.11.005","article-title":"Aspirin use among adults in the U.S.: results of a national survey","volume":"48","author":"Williams","year":"2015","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.annepidem.2018.03.006_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/2042098611435911","article-title":"Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource","volume":"3","author":"Williams","year":"2012","journal-title":"Ther Adv Drug Saf"},{"issue":"3","key":"10.1016\/j.annepidem.2018.03.006_bib15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"7","key":"10.1016\/j.annepidem.2018.03.006_bib16","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/jac\/dkw084","article-title":"Understanding flucloxacillin prescribing trends and treatment non-response in UK primary care: a Clinical Practice Research Datalink (CPRD) study","volume":"71","author":"Francis","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.annepidem.2018.03.006_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1471-2288-11-168","article-title":"Potential application of item-response theory to interpretation of medical codes in electronic patient records","volume":"11","author":"Dregan","year":"2011","journal-title":"BMC Med Res Methodol"},{"issue":"9","key":"10.1016\/j.annepidem.2018.03.006_bib18","doi-asserted-by":"crossref","first-page":"e7168","DOI":"10.1371\/journal.pone.0007168","article-title":"Selection of medical diagnostic codes for analysis of electronic patient records. Application to stroke in a primary care database","volume":"4","author":"Gulliford","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.annepidem.2018.03.006_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2458-11-86","article-title":"Utility of electronic patient records in primary care for stroke secondary prevention trials","volume":"11","author":"Dregan","year":"2011","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.annepidem.2018.03.006_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.canep.2012.05.013","article-title":"Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study","volume":"36","author":"Dregan","year":"2012","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"10.1016\/j.annepidem.2018.03.006_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ageing\/afw039","article-title":"Development and validation of an electronic frailty index using routine primary care electronic health record data","volume":"45","author":"Clegg","year":"2016","journal-title":"Age Ageing"},{"key":"10.1016\/j.annepidem.2018.03.006_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A\u00a0global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"Can Med Assoc J"},{"issue":"3","key":"10.1016\/j.annepidem.2018.03.006_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/clpt.2011.258","article-title":"High-risk prescribing and incidence of frailty among older community-dwelling men","volume":"91","author":"Gnjidic","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.annepidem.2018.03.006_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ageing\/afv166","article-title":"Use of a frailty index to identify potentially inappropriate prescribing and adverse drug reaction risks in older patients","volume":"45","author":"Cullinan","year":"2016","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.annepidem.2018.03.006_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jgs.13877","article-title":"Effects of changes in number of medications and drug burden index exposure on transitions between frailty states and death: the concord health and ageing in men project cohort study","volume":"64","author":"Jamsen","year":"2016","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"7","key":"10.1016\/j.annepidem.2018.03.006_bib26","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0002-9149(02)02606-1","article-title":"Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial)","volume":"90","author":"Cannon","year":"2002","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.annepidem.2018.03.006_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.103.3.363","article-title":"Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery","volume":"103","author":"Bhatt","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.annepidem.2018.03.006_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","article-title":"Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association\/american stroke association","volume":"42","author":"Furie","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.annepidem.2018.03.006_bib29","series-title":"The management of atrial fibrillation","author":"National Institute for Clinical Excelence","year":"2014"},{"key":"10.1016\/j.annepidem.2018.03.006_bib30","series-title":"Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation","author":"National Institute for Health and Care Excellence","year":"2012"},{"issue":"9","key":"10.1016\/j.annepidem.2018.03.006_bib31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/pds.1987","article-title":"Antithrombotic therapies in patients with heart failure: hypothesis formulation from a research database","volume":"19","author":"Yuan","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.annepidem.2018.03.006_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amepre.2009.08.029","article-title":"Use of antithrombotic agents among U.S. stroke survivors, 2000-2006","volume":"38","author":"Cheng","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.annepidem.2018.03.006_bib33","article-title":"Trajectory of Total Cholesterol in The Last Years of Life Over Age 80 Years. Cohort Study of 99,758 Participants","author":"Charlton","year":"2017","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.annepidem.2018.03.006_bib34","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2147\/TCRM.S84210","article-title":"New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events","volume":"11","author":"Mekaj","year":"2015","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"10.1016\/j.annepidem.2018.03.006_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jacc.2014.03.049","article-title":"Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis","volume":"64","author":"Halvorsen","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.annepidem.2018.03.006_bib36","first-page":"1","article-title":"The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction","volume":"21","author":"Platt","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.1016\/j.annepidem.2018.03.006_bib37","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/art.22663","article-title":"Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals","volume":"56","author":"Erkan","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.annepidem.2018.03.006_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/1755-5922.12129","article-title":"Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation","volume":"33","author":"Steinberg","year":"2015","journal-title":"Cardiovasc Ther"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279717311833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279717311833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:22:00Z","timestamp":1760926920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279717311833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1047279717311833"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2018.03.006","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term trends in antithrombotic drug prescriptions among adults aged 80\u00a0years and over from primary care: a temporal trends analysis using electronic health records","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2018.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}